Anti-Human FGR Antibody Pair

Anti-Human FGR Antibody Pair
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ABS-ES-1616.1 1 pair (100 µg/100 µg) - -

10 - 14 Werktage*

1.080,00 €
 
Product Description: FGR proto-oncogene, Src family tyrosine kinase (FGR) is a member of the Src... mehr
Produktinformationen "Anti-Human FGR Antibody Pair"
Product Description: FGR proto-oncogene, Src family tyrosine kinase (FGR) is a member of the Src family of protein tyrosine kinases. The protein contains N-terminal sites for myristoylation and palmitoylation, a PTK domain, and SH2 and SH3 domains involved in protein-protein interactions. FGR functions as a non-receptor tyrosine kinase that transmits signals from cell surface receptors and regulates immune responses, including neutrophil, monocyte, macrophage, and mast cell functions. It plays a role in cytoskeleton remodeling, phagocytosis, cell adhesion, and migration. FGR is involved in mast cell degranulation and the release of inflammatory cytokines. Diseases associated with FGR include placental insufficiency and endometriosis of pelvic peritoneum. The protein localizes to plasma membrane ruffles and negatively regulates cell migration and adhesion triggered by the beta-2 integrin signal transduction pathway. Protein Function: Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors devoid of kinase activity and contributes to the regulation of immune responses, including neutrophil, monocyte, macrophage and mast cell functions, cytoskeleton remodeling in response to extracellular stimuli, phagocytosis, cell adhesion and migration. Promotes mast cell degranulation, release of inflammatory cytokines and IgE-mediated anaphylaxis. Acts downstream of receptors that bind the Fc region of immunoglobulins, such as MS4A2/FCER1B, FCGR2A and/or FCGR2B. Acts downstream of ITGB1 and ITGB2, and regulates actin cytoskeleton reorganization, cell spreading and adhesion. Depending on the context, activates or inhibits cellular responses. Functions as a negative regulator of ITGB2 signaling, phagocytosis and SYK activity in monocytes. Required for normal ITGB1 and ITGB2 signaling, normal cell spreading and adhesion in neutrophils and macrophages. Functions as a positive regulator of cell migration and regulates cytoskeleton reorganization via RAC1 activation. Phosphorylates SYK (in vitro) and promotes SYK-dependent activation of AKT1 and MAP kinase signaling. Phosphorylates PLD2 in antigen-stimulated mast cells, leading to PLD2 activation and the production of the signaling molecules lysophosphatidic acid and diacylglycerol. Promotes activation of PIK3R1. Phosphorylates FASLG, and thereby regulates its ubiquitination and subsequent internalization. Phosphorylates ABL1. Promotes phosphorylation of CBL, CTTN, PIK3R1, PTK2/FAK1, PTK2B/PYK2 and VAV2. Phosphorylates HCLS1 that has already been phosphorylated by SYK, but not unphosphorylated HCLS1. Together with CLNK, it acts as a negative regulator of natural killer cell-activating receptors and inhibits interferon-gamma production (By similarity) [The Uniprot Consortium]
Schlagworte: Anti-FGR, Anti-p58-Fgr, Anti-p55-Fgr, Anti-p58c-Fgr, Anti-Proto-oncogene c-Fgr, Anti-Tyrosine-protein kinase Fgr, Anti-Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog, Human FGR Antibody Pair
Hersteller: Absea
Hersteller-Nr: ES-1616

Eigenschaften

Anwendung: ELISA
Antikörper-Typ: Monoclonal
Klon: K06346_4D4/K94033_19B12
Konjugat: No
Wirt: Mouse/Mouse
Spezies-Reaktivität: human
Reinheit: >85%
Format: Solution

Handhabung & Sicherheit

Lagerung: -20°C (avoid repeat freezing and thawing cycles)
Versand: -20°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier folgen Informationen zur Produktreferenz. mehr
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-Human FGR Antibody Pair"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen